Condition

Peripheral Neuropathy Due to Chemotherapy clinical trials and research

• 6Clinical trials
• 2Countries

Newest Peripheral Neuropathy Due to Chemotherapy clinical trials

All recruiting trials (6)

• Preventing taxane-related peripheral neuropathy with oral mecobalamin

  This trial will test whether taking oral mecobalamin during taxane chemotherapy can prevent or reduce numbness, tingling, and pain in the hands and feet of adults with solid tumors.

  Recruiting at 2 sites Phase 3 Qinghai Red Cross Hospital · Xining, Qinghai and 3 other locations · NCT07423390

• Cannabidiol (CBD) to prevent nerve damage from oxaliplatin chemotherapy

  This pilot will test whether hemp-derived cannabidiol (CBD) taken during oxaliplatin chemotherapy can prevent nerve damage in people with metastatic colorectal cancer.

  Recruiting Early Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07167446

• Nerve excitability testing for cisplatin-related peripheral neuropathy

  This study will see if specialized nerve excitability tests (TTNCS) can detect early nerve changes in adults starting cisplatin or who recently finished cisplatin and have peripheral neuropathy.

  Recruiting Beth Israel Deaconess Medical Center · Boston, Massachusetts and 1 other locations · NCT07095998

• Walkasins to improve balance for people with peripheral neuropathy

  This project will test whether daily use of Walkasins helps people with peripheral neuropathy improve foot-placement awareness and balance over six months.

  Recruiting at 4 sites RxFunction Inc. · Mesa, Arizona and 5 other locations · NCT06959277

• Topical capsaicin for pain and walking problems from chemotherapy-related peripheral neuropathy

  This will try an 8% capsaicin patch on adults with chemotherapy-related peripheral neuropathy to see if it lowers pain and improves walking.

  Recruiting Early Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT06744816

• Botulinum toxin A to treat chemotherapy-related peripheral neuropathy

  This trial will try small intradermal injections of IncobotulinumtoxinA (Xeomin) to see if they reduce neuropathic pain in breast cancer patients who developed neuropathy after taxane chemotherapy.

  Recruiting Phase 2 Medical College of Wisconsin · Milwaukee, Wisconsin · NCT03571334

Related topics

Quick answers

How many Peripheral Neuropathy Due to Chemotherapy clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (5 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →